O'Shaughnessy Asset Management
AMRX icon

O'Shaughnessy Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.82M Sell
141,490
-3,215
-2% -$57.9K 0.01% 805
2026
Q2 		$2.5M Buy
144,705
+13,637
+10% +$187K 0.01% 815
2026
Q1 		$1.63M Sell
131,068
-25,273
-16% -$339K 0.01% 965
2025
Q4 		$1.97M Buy
156,341
+7,931
+5% +$90.7K 0.01% 850
2025
Q3 		$1.49M Buy
148,410
+643
+0.4% +$5.77K 0.01% 952
2025
Q2 		$1.2M Sell
147,767
-18,923
-11% -$143K 0.01% 988
2025
Q1 		$1.4M Sell
166,690
-8,909
-5% -$74.4K 0.01% 849
2024
Q4 		$1.39M Sell
175,599
-28,190
-14% -$236K 0.01% 803
2024
Q3 		$1.76M Sell
203,789
-1,151
-0.6% -$9K 0.02% 688
2024
Q2 		$1.3M Buy
204,940
+15,655
+8% +$99.4K 0.01% 744
2024
Q1 		$1.15M Buy
189,285
+39,706
+27% +$224K 0.01% 777
2023
Q4 		$908K Buy
149,579
+46,802
+46% +$208K 0.01% 787
2023
Q3 		$434K Buy
+102,777
New +$383K 0.01% 982
2023
Q1 		– Sell
-11,712
Closed -$23.3K – 1480
2022
Q4 		$23.3K Sell
11,712
-542
-4% -$1.22K ﹤0.01% 1296
2022
Q3 		$25K Buy
12,254
+542
+5% +$1.52K ﹤0.01% 1258
2022
Q2 		$37K Buy
+11,712
New +$42.4K ﹤0.01% 1166
2021
Q3 		– Sell
-61
Closed – – 2708
2021
Q2 		$0 Buy
+61
New +$347 ﹤0.01% 2562

Other funds holding AMRX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

O'Shaughnessy Asset Management's AMRX Position: Q3 2026 in Review

O'Shaughnessy Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 2.2% in Q3 2026, selling an estimated $57.9K and leaving 141,490 shares worth $2.82M. The position accounts for 0.01% of the portfolio, ranked #805.

O'Shaughnessy Asset Management first reported a position in AMRX in Q2 2021 and has held it in 17 quarters since. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • O'Shaughnessy Asset Management held 141,490 shares of Amneal Pharmaceuticals worth $2.82M as of Q3 2026.
  • O'Shaughnessy Asset Management sold 3,215 Amneal Pharmaceuticals shares in Q3 2026, an estimated $57.9K.
  • Amneal Pharmaceuticals made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q3 2026, its #805 holding.
  • O'Shaughnessy Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
  • 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.